Common use of Minimum LTM EBITDA Clause in Contracts

Minimum LTM EBITDA. Not permit the EBITDA of the Borrower and its Subsidiaries or Holdings and its Subsidiaries as the context may require after giving effect to the De-SPAC Transactions, as of the last day of any Test Period set forth in the table below, to be less than the amount set forth opposite such Test Period for such Test Period then ended: Test Period Ended Minimum LTM EBITDA December 31, 2020 ($12,792,000) March 31, 2021 ($11,766,000) June 30, 2021 ($7,717,000) September 30, 2021 $2,000,000 December 31, 2021 $9,500,000 March 31, 2022 $19,500,000 June 30, 2022 $29,000,000 September 30, 2022 $32,000,000 December 31, 2022 $32,000,000 March 31, 2023 $32,000,000 June 30, 2023 $32,000,000 September 30, 2023 $32,000,000 December 31, 2023 $32,000,000 March 31, 2024 $32,000,000 June 30, 2024 $32,000,000 September 30, 2024 $32,000,000 December 31, 2024 $32,000,000

Minimum LTM EBITDA. Not permit the EBITDA of the Borrower and its Subsidiaries or Holdings and its Subsidiaries as the context may require after giving effect to the De-SPAC Transactions, as of the last day of any Test Period set forth in the table below, to be less than the amount set forth opposite such Test Period for such Test Period then ended: Test Period Ended Minimum LTM EBITDA December 31, 2020 $ ($12,792,00012,792,000 ) March 31, 2021 $ ($11,766,00011,766,000 ) June 30, 2021 $ ($7,717,0007,717,000 ) September 30, 2021 $$ 2,000,000 December 31, 2021 $$ 9,500,000 March 31, 2022 $$ 19,500,000 June 30, 2022 $$ 29,000,000 September 30, 2022 $$ 32,000,000 December 31, 2022 $$ 32,000,000 March 31, 2023 $$ 32,000,000 June 30, 2023 $$ 32,000,000 September 30, 2023 $$ 32,000,000 December 31, 2023 $$ 32,000,000 March 31, 2024 $$ 32,000,000 June 30, 2024 $$ 32,000,000 September 30, 2024 $$ 32,000,000 December 31, 2024 $$ 32,000,000

Minimum LTM EBITDA. Not permit the EBITDA of the Borrower and its Subsidiaries or Holdings and its Subsidiaries as the context may require after giving effect to the De-SPAC TransactionsSubsidiaries, as of the last day of any Test Period set forth in the table below, to be less than the amount set forth opposite such Test Period for such Test Period then ended: Test Period Ended Minimum LTM EBITDA March 31, 2022 $ (42,000,000 ) June 30, 2022 $ (48,000,000 ) September 30, 2022 $ (42,000,000 ) December 31, 2020 2022 $ ($12,792,00039,000,000 ) March 31, 2021 2023 $ ($11,766,00023,000,000 ) June 30, 2021 2023 $ ($7,717,00023,000,000 ) September 30, 2021 $2,000,000 December 31, 2021 $9,500,000 March 31, 2022 $19,500,000 June 30, 2022 $29,000,000 September 30, 2022 $32,000,000 December 31, 2022 $32,000,000 March 31, 2023 $32,000,000 June 30, 2023 $32,000,000 September 30, 2023 $32,000,000 $ (21,000,000 ) December 31, 2023 $32,000,000 $ (16,000,000 ) March 31, 2024 $32,000,000 $ (16,000,000 ) June 30, 2024 $32,000,000 $ (10,000,000 ) September 30, 2024 $32,000,000 December 31, 2024 $32,000,000$ (5,000,000 )